Fig. 4From: Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney diseaseThe relative mRNA expression levels of a CCL 19, b IL7R, c GHR, d FGF1, e FYN, f VEGFA, g F2R, h TGFBR3, i PTGDS, j FGF9, and k SEMA5A in the NC and HG group. NC, normal control; HG, high-glucose; ns: P > 0.05; *P < 0.05; **P < 0.01Back to article page